Studien

ALLRT

AIDS clinical trials group Longitudinal Linked Randomized Trials

ALLSTAR

RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors

ALLY

Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial

ALLY-1

Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Subjects and Subjects Post-liver Transplant

ALLY-2

Phase III HIV/HCV Co-Infection Daclatasvir (DCV)+ Sofosbuvir (SOF)

ALLY-3

Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV

ALM

Arbeitsgruppe LeberMetastasen

ALM-CAO

Arbeitsgruppe Lebermetastasen und -tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie

ALMANAC

Axillary Lymphatic Mapping Against Nodal Axillary Clearance

ALMS

Aspreva Lupus Management Study

ALNN

Asian Lupus Nephritis Network

ALOFT

ALiskiren Observation of heart Failure Treatment

ALOHA

Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern

ALPACA

A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]

AlPaCKa

Apelin as a Potential Treatment for Chronic Kidney Disease

ALPADIR

A Randomized, Placebo-Controlled Study of High-Dose Baclofen in Alcohol-Dependent Patients

ALPHA

Analysing Longitudinal Population-based HIV/AIDS data on Africa

ALPHA

Danicopan as Add-on Therapy to a C5 Inhibitor in Paroxysmal Nocturnal Hemoglobinuria (PNH) Participants Who Have Clinically Evident Extravascular Hemolysis (EVH)

ALPHA

Predictors of Mortality and Hospitalization for Cardiac Causes in Patients With Heart Failure and Nonischemic Heart Disease

ALPHA

Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/​Refractory Large B Cell or Follicular Lymphoma

Alpha Omega Trial

Alpha Omega Trial: Study of Omega-3 Fatty Acids and Coronary Mortality

Alpha-Stim-D

A randomised controlled trial investigating the clinical and cost-effectiveness of Alpha-Stim AID cranial electrotherapy stimulation (CES) in patients seeking treatment for moderate severity depression in primary care

ALPHA2/ALPHA

Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

ALPHEE

Amiodarone as calibrator for the prevention of implantable cardioverter defibrillator interventions or death

ALPI

Adjuvant Lung Project Italy

ALPINE

A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia

ALPINE

Antihypertensive treatment and Lipid Profile In a North of Sweden Efficacy evaluation

Alpine CHRIS

Cooperative Health Research In South Tyrol

ALPS

Amiodarone, Lidocaine or Placebo Study

ALPS

Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis

ALS riluzole-tocopherol Study

A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis

ALSPAC

Avon Longitudinal Study of Parents And Children

ALSPAC

Avon Longitudinal Study of Pregnancy And Childhood

Alster-Lost-AF Trial

Ablation at St. Georg Hospital for Long-Standing Persistent Atrial Fibrillation

ALSummit

Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients With ALS

ALSWH

Australian Longitudinal Study on Women’s Health

ALSYMPCA

ALpharadin in SYMPtomatic prostate CAncer patients

ALt FLOW CANADA

Exploratory Study of the Edwards Transcatheter Atrial Shunt System

ALT FLOW Early Feasibility Study

Early Feasibility Study - Edwards APTURE Transcatheter Shunt System

ALTA-1L

ALK in Lung cancer Trial of Brigatinib in 1st Line

ALTAI

A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD)

ALTAIR

Abatacept Leading Trial for RA on Imaging Remission

ALTAIR

ALTernative Antiretroviral strategies: a comparison of three Initial Regimens

ALTAIR

Efficacy of ALirocumab for Thin-cap fibroatheroma in patients with coronary Artery disease estImated by optical coherence tomography

ALTAR

ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women

ALTE1621

Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors

ALTERNATE

Assessing a biomarker driven strategy for the treatment of post-menopausal women with ER+/Her2− invasive breast cancer

ALTERNATIVE

A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer

ALTITUDE

ALiskiren Trial In Type 2 diabetes Using carDio-renal Endpoints

ALTITUDE

Long-term outcome after ICD and CRT implantation and influence of remote device follow-up

ALTITUDE survival by rhythm study

Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked

ALTOS

Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials

ALTS

ASCUS/LSIL (ASCUS = Atypical Squamous cells of undetermined significance; LSIL = low-grade squamous intraepithelial lesion)

Altshock-2

Early intra-aortic balloon pump in acute decompensated heart failure complicated by cardiogenic shock

ALTTO (BIG 2-06)

Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation study

ALU

A randomized controlled single-blind multi-centre study to investigate the induction of ALUminium contact allergy in children/adults receiving hyposensitisation therapy due to allergic disease

AMACING

A MAastricht Contrast-Induced Nephropathy Guidelines study

AMADEO

A comparison of telMisartan versus losArtan in hypertensive type 2 DiabEtic patients with Overt nephropathy

AMADEUS

CARILLON Mitral Annuloplasty Device European Union Study

AMADEUS

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation